In vitro evaluation of aerosol delivery of aztreonam lysine (AZLI): an adult mechanical ventilation model

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2017-10-23

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1080/17425247.2017.1393411PMID 29041861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review

  2016cited by this paper
• Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient

  2016cited by this paper
• Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

  2016cited by this paper
• Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia.

  2016cited by this paper
• Effects of parent and child behaviours on overweight and obesity in infants and young children from disadvantaged backgrounds: systematic review with narrative synthesis

  2016cited by this paper
• Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study.

  2015cited by this paper
• In Vitro Performance of Spacers for Aerosol Delivery during Adult Mechanical Ventilation

  2015cited by this paper
• Ventilator-associated infection: the role for inhaled antibiotics

  2015cited by this paper
• Aerosolized Antibiotics

  2015cited by this paper
• Nebulized antibiotics. An adequate option for treating ventilator-associated respiratory infection?

  2015cited by this paper
• Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis

  2015cited by this paper
• Nebulized antibiotics. An adequate option for treating ventilator-associated respiratory infection?

  2015cited by this paper
• Influence of Inspiratory Flow Pattern and Nebulizer Position on Aerosol Delivery with a Vibrating-Mesh Nebulizer During Invasive Mechanical Ventilation: An in Vitro Analysis

  2014cited by this paper
• Nebulized colistin for non-cystic fibrosis bronchiectasis: déjà vu all over again?

  2014cited by this paper
• Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit.

  2014cited by this paper
• A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients.

  2014cited by this paper
• Encapsulation into PEG-Liposomes Does Not Improve the Bioavailability of Pulmonary Delivered Salmon Calcitonin

  2014cited by this paper
• Aerosol therapy during mechanical ventilation: an international survey

  2013cited by this paper
• Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.

  2013cited by this paper
• Thoracic and respirable particle definitions for human health risk assessment

  2013cited by this paper
• Aerosolized antibiotics: do they add to the treatment of pneumonia?

  2013cited by this paper
• Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii

  2012cited by this paper
• Aerosolized Antibiotics for Ventilator-associated Pneumonia: Lessons from Experimental Studies

  2012cited by this paper
• An In Vitro Evaluation of Aerosol Delivery Through Tracheostomy and Endotracheal Tubes Using Different Interfaces

  2012cited by this paper
• Aerosolized antibiotics in the intensive care unit.

  2011cited by this paper
• Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update

  2011cited by this paper
• Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

  2011cited by this paper
• Aerosol drug delivery: developments in device design and clinical use.

  2011cited by this paper
• An 18‐month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

  2010cited by this paper
• Factors affecting bronchodilator delivery in mechanically ventilated adults.

  2010cited by this paper
• Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection

  2009cited by this paper
• Aerosolized antibiotics in critically ill ventilated patients

  2009cited by this paper
• Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes.

  2009cited by this paper
• Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.

  2009cited by this paper
• Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

  2008cited by this paper
• Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects

  2008cited by this paper
• Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit*

  2008cited by this paper
• Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis

  2006cited by this paper
• Factors Influencing the In Vitro Deposition of Tobramycin Aerosol: A Comparison of an Ultrasonic Nebulizer and a High-Frequency Vibrating Mesh Nebulizer

  2006cited by this paper
• Aerosol Deposition in Neonatal Ventilation

  2005cited by this paper
• Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

  2005cited by this paper
• Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome

  2002cited by this paper
• The efficiency of β2-agonist delivery through tracheal tubes with the metered-dose inhaler: an in vitro study

  2002cited by this paper
• A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

  2002cited by this paper
• Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats.

  2001cited by this paper
• Special problems in aerosol delivery: artificial airways.

  2000cited by this paper
• Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.

  1999cited by this paper
• Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.

  1999cited by this paper
• The delivery of therapeutic aerosols through endotracheal tubes

  1986cited by this paper

• Performance of newly developed add-on devices on aerosol delivery in noninvasive ventilated subjects

  2024cites this paper
• Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease are Serotype Dependent.

  2020influential citation
• Comparative lung distribution of radiolabelled tobramycin between nebulized and intravenous administration in a mechanically ventilated ovine model, an observational study.

  2020cites this paper
• Characterisation of 40 mg/ml and 100 mg/ml tobramycin formulations for aerosol therapy with adult mechanical ventilation.

  2018cites this paper